SMT, PCB Electronics Industry News

Rapid Response Strep A Tests

Oct 16, 2009

BTNX’S Rapid Response® Strep A test is a qualitative lateral flow immunoassay for the detection of group A streptococcus, or group A strep, carbohydrate antigen in a throat swab for professional in-vitro diagnostic.

Toronto, Canada – BTNX Inc. has launched a Rapid Response® advanced FDA cleared & CLIA waived in-vitro diagnostic group A streptococcus, or strep A, test, which is a qualitative lateral flow immunoassay for the detection of strep A carbohydrate antigen in a throat swab.

Strep A is a bacterium that is commonly found in the throat and on the skin. Strep A bacteria might cause no symptoms of disease, but they can also cause infections that range from mild to life-threatening.

Strep A bacteria are spread by direct person-to-person contact. The bacteria are carried in discharges from nose or throat of an infected person and in infected wounds or sores on the skin. The bacteria are usually spread when infected secretions come in the contact with the mouth, nose, or eyes of an uninfected person.

Strep A bacteria usually causes relatively mild illnesses, such as streptococcal sore throat (strep throat) and streptococcal skin infections (impetigo). It can also cause more serious illnesses such as scarlet fever, rheumatic fever, postpartum fever, wound infections, and pneumonia.

Occasionally, a deadly type of strep A bacteria can invade the blood, muscle and fat tissue, or lungs and cause a serious and often life- threatening type infections.

Rapid Response® Strep A test is FDA cleared and CLIA waived, offers 95% accuracy v/s culture (gold Stand) in rare and 1+ colonies and results within 5 minutes, and has no cross reaction with other ?-hemolytic streptococci.

Rapid Response® branded tests are trusted by professionals in laboratories, physicians’ offices, hospitals and clinics worldwide for their diagnostic testing requirements.

BTNX Inc. is a biotechnology company and a world leader in rapid, point-of-care diagnostics. BTNX Inc. specializes in innovation, research, development and manufacturing of advanced in-vitro diagnostic (IVD) tests and information technology systems to manage point-of-care diagnostic test results using HL7/POCT1-A2 compliant software solutions for laboratories, clinics, hospitals and physicians’ offices.

For more information about the products please visit http://www.BTNX.com , or contact Sales@BTNX.com.

Oct 16, 2009 -

Rapid Response® Point of Care Drugs of Abuse Tests

Oct 16, 2009 -

BTNX Offers Free Blood Glucose Meters

Jul 23, 2017 -

PDR Americas Partners with Orr Marketing, Inc. in the Carolinas

Jul 23, 2017 -

Zuken Announces XJTAG DFT Assistant for CR-8000 PCB design suite

Jul 23, 2017 -

SMTA Welcomes New Board Members

Jul 23, 2017 -

SMTA International Technical Program Expands, Includes Research from HDPUG and AREA Consortium

Jul 23, 2017 -

Senator Ron Johnson Discusses U.S. Policy Priorities in Townhall Discussion with IPC-member Company, VirTex MTI

Jul 21, 2017 -

Epec Now Offering PCB Layout and Design Services

Jul 21, 2017 -

Help customer solve problems of 750L machine

Jul 19, 2017 -

Digicom Electronics Receives AS9100:2016 (RevD) Aerospace and ISO 9001:2015 Certifications

Jul 19, 2017 -

Conecsus Presents SMT Metals Waste Recycling Solutions at SMTAI 2017

Jul 19, 2017 -

New Metcal HTD Tips & Hand-piece Increase Throughput and Save Money

See electronics manufacturing industry news »

Rapid Response Strep A Tests news release has been viewed 616 times

Used SMT machines

Capillary Underfill process